Research graph
References from Absolute monocyte counts could predict disease activity and secondary loss of response of patients with Crohn’s disease treated with anti-TNF-α drug. Local targets link to admitted publications; unresolved targets remain external evidence.
Diagnosis and classification of Crohn’s disease [J].
10.1016/j.autrev.2014.01.029 · 2014 · External reference
Accuracy of the highly sensitive C-reactive protein/albumin ratio to determine disease activity in inflammatory bowel disease [J].
10.1097/md.0000000000025200 · 2021 · External reference
Diagnostic Accuracy of Fecal Calprotectin for Predicting Relapse in Inflammatory Bowel Disease: A Meta-Analysis [J].
2023 · External reference
Clinical value of fecal calprotectin for evaluating disease activity in patients with Crohn’s disease [J].
10.3389/fphys.2023.1186665 · 2023 · External reference
The role of small bowel capsule endoscopy and ileocolonoscopy in patients with nonspecific but suggestive symptoms of Crohn’s disease [J]
10.1097/meg.0000000000000644 · 2016 · External reference
ADALIMUMAB VERSUS INFLIXIMAB IN LUMINAL PEDIATRIC CROHN’S DISEASE: COMPARABLE OUTCOMES IN A PROSPECTIVE MULTICENTER COHORT STUDY [J]
2023 · External reference
P014 Postoperative Recurrence in Crohn’s Disease Patients Treated with Adalimumab versus Infliximab: A Systematic Review and Meta-Analysis [J]
10.14309/01.ajg.0000798656.34221.7f · 2021 · External reference
Systematic review with network meta-analysis: the efficacy of anti-TNF agents for the treatment of Crohn’s disease [J]
10.1111/apt.12749 · 2014 · External reference
Early drug and anti-infliximab antibody levels for prediction of primary nonresponse to infliximab therapy [J]
10.1111/apt.14410 · 2018 · External reference
The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn’s and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response? [J]
10.1038/ajg.2010.392 · 2011 · External reference
The state of the art on treatment of Crohn’s disease [J]
10.1007/s00535-018-1479-6 · 2018 · External reference
Monocyte recruitment during infection and inflammation [J]
10.1038/nri3070 · 2011 · External reference
Pathophysiology of Inflammatory Bowel Disease: Innate Immune System [J].
2023 · External reference
Monocytosis Is a Biomarker of Severity in Inflammatory Bowel Disease: Analysis of a 6-Year Prospective Natural History Registry [J].
10.1093/ibd/izab031 · 2022 · External reference
Peripheral Blood Monocytosis Is Associated With Long-Term Disease Severity in Pediatric-Onset Inflammatory Bowel Disease [J]
10.1097/mpg.0000000000003755 · 2023 · External reference
Monocytosis and a Low Lymphocyte to Monocyte Ratio Are Effective Biomarkers of Ulcerative Colitis Disease Activity [J]
10.1097/mib.0000000000000427 · 2015 · External reference
Disease Characteristics and Severity in Patients With Inflammatory Bowel Disease With Coexistent Diabetes Mellitus [J].
10.1093/ibd/izz305 · 2020 · External reference
Increased monocyte abundance as a marker for relapse after discontinuation of biologics in inflammatory bowel disease with deep remission [J].
10.3389/fimmu.2022.996875 · 2022 · External reference
Usefulness of peripheral blood monocyte count to predict relapse in patients with inflammatory bowel disease: a prospective longitudinal cohort study [J].
2022 · External reference
Development of a Crohn’s disease activity index. National Cooperative Crohn’s Disease Study [J].
10.1016/s0016-5085(76)80163-1 · 1976 · External reference
Predictors of Primary Response to Biologic Treatment [Anti-TNF, Vedolizumab, and Ustekinumab] in Patients With Inflammatory Bowel Disease: From Basic Science to Clinical Practice [J].
10.1093/ecco-jcc/jjz195 · 2020 · External reference
Collinearity in multivariable analysis: causes, detection and control measures] [J].
2009 · External reference
Standardizing the power of the Hosmer-Lemeshow goodness of fit test in large data sets [J].
10.1002/sim.5525 · 2013 · External reference
Reflection on modern methods: Revisiting the area under the ROC Curve [J]
10.1093/ije/dyz274 · 2020 · External reference
Serum Albumin to Globulin Ratio is Associated with the Presence and Severity of Inflammatory Bowel Disease [J]
10.2147/jir.s347161 · 2022 · External reference
The Relationship between Serum Bilirubin and Inflammatory Bowel Disease [J].
10.1155/2019/5256460 · 2019 · External reference
Utilization of Treat-to-Target Monitoring Colonoscopy After Treatment Initiation in the US-Based Study of a Prospective Adult Research Cohort With Inflammatory Bowel Disease [J]
External reference
Update on C-reactive protein and fecal calprotectin: are they accurate measures of disease activity in Crohn’s disease? [J].
10.1080/17474124.2019.1563481 · 2019 · External reference
Combined Use of Common Fecal and Blood Markers for Detection of Endoscopically Active Inflammatory Bowel Disease [J].
10.14309/ctg.0000000000000138 · 2020 · External reference
Investigating the role of proinflammatory CD16+ monocytes in the pathogenesis of inflammatory bowel disease [J]
10.1111/j.1365-2249.2010.04177.x · 2010 · External reference
Annickia polycarpa extract attenuates inflammation, neutrophil recruitment, and colon damage during colitis [J]
10.1016/j.imlet.2022.07.006 · 2022 · External reference
Recruitment of activated neutrophils correlates with disease severity in adult Crohn’s disease [J]
10.1111/cei.13226 · 2019 · External reference
Can Neutrophil/Lymphocyte Ratio Assess Inflammatory Bowel Disease Activity and Severity in Children? [J]
10.5152/tjg.2022.21889 · 2022 · External reference
Inflammatory Bowel Disease and Neutrophil-Lymphocyte Ratio: A Systematic Scoping Review [J].
2021 · External reference
Monocytes from infliximab-resistant patients with Crohn’s disease exhibit a disordered cytokine profile [J].
10.1038/s41598-020-68993-1 · 2020 · External reference
Can We Predict the Efficacy of Anti-TNF-α Agents? [J].
2017 · External reference
The protease inhibitor cystatin C down-regulates the release of IL-β and TNF-α in lipopolysaccharide activated monocytes [J]
10.1189/jlb.5a0415-174r · 2016 · External reference
Level of Tumor Necrosis Factor Production by Stimulated Blood Mononuclear Cells Can Be Used to Predict Response of Patients With Inflammatory Bowel Diseases to Infliximab [J]
10.1016/j.cgh.2020.03.066 · 2021 · External reference
Infliximab induces apoptosis in monocytes from patients with chronic active Crohn’s disease by using a caspase-dependent pathway [J]
10.1053/gast.2001.28702 · 2001 · External reference
Monocyte TREM-1 Levels Associate With Anti-TNF Responsiveness in IBD Through Autophagy and Fcγ-Receptor Signaling Pathways [J].
10.3389/fimmu.2021.627535 · 2021 · External reference
